Moreover, some preclinical studies also reported that anti-PD-1 monotherapy could induce anti-tumour immunological memory in C57BL/6 immunocompetent mice bearing the GL261 tumour [16,30]. The gene discussed is PDCD1; the disease is neoplasm.